HEALTHCARE
Global Hybrid Imaging Market - Industry Trends and Forecast to 2032
REPORT OVERVIEW
Global Hybrid Imaging Market, By Technology (X-ray Imaging Systems, X-ray Digital Imaging Systems, X-ray Analog Imaging Systems), Type (PET/CT systems, SPET/CT systems, PET/MR systems, OCT/Fundus Imaging System, Others), SPECT Market (Standalone SPECT System, Hybrid SPECT System), Application (Oncology, Ophthalmology, Cardiology, Brain & Neurology, Other Applications), End Use (Hospitals, Diagnostic Imaging Centers, Others), Region (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2032.
Market Insights
Market Dynamics
- Increasing significance of combination analysis of anatomic and molecular data
- High prevalence of chronic diseases
- High cost of hybrid imaging systems.
- Limited reimbursement policies in some regions.
- Increasing occurrences of chronic diseases, with cancer
- Governments of various countries are taking favorable initiatives
- Integration challenges with existing healthcare IT systems.
- Data privacy and security concerns.
SEGMENTATION
- Technology
- X-ray Imaging Systems
- X-ray Digital Imaging Systems
- Computed Radiography
- Direct Radiography
- X-ray Analog Imaging Systems
- Computed Tomography (CT) Scanners
- High-slice CT Scanners
- Mid-slice CT Scanners
- Low-slice CT Scanners
- Ultrasound Systems
- 2D Imaging
- 3D and 4D Imaging
- Doppler Imaging
- Magnetic Resonance Imaging (MRI) Systems
- High- and Very-high-field MRI Systems
- Low-to-mid-field MRI Systems
- Ultra-high-field MRI Systems
- Nuclear Imaging Systems [Single-photon Emission Computed Tomography (SPECT) and Photon Emission Tomography (PET) Systems]
- Type
- PET/CT systems
- SPET/CT systems
- PET/MR systems
- OCT/Fundus Imaging System
- Others
- SPECT Market
- Standalone SPECT System
- Hybrid SPECT System
- Application
- Oncology
- Ophthalmology
- Cardiology
- Brain & Neurology
- Other Applications
- End Use
- Hospitals
- Diagnostic Imaging Centers
- Others
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- The Netherlands
- Belgium
- Turkey
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Singapore
- Malaysia
- Australia
- Thailand
- Philippines
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Chile
- Colombia
- Rest of South America
- Middle East and Africa
- Kingdom of Saudi Arabia
- South Africa
- U.A.E.
- Egypt
- Rest of Middle East and Africa
KEY MARKET PLAYERS
- GE HealthCare
- Siemens Healthcare
- Koninklijke Philips N.V.
- CANON MEDICAL SYSTEMS CORPORATION
- Shanghai United Imaging Healthcare Co., LTD
- TTG IMAGING SOLUTIONS (Digirad)
- Carl Zeiss Meditec AG
- Topcon Corporation
- Heidelberg Engineering
- NIDEK
Table OF CONTENTS
- SECTION 1 - INTRODUCTION
- 1.1 Taxonomy
- 1.2 Market Overview
- 1.3 Currency and Limitations
- 1.3.1 Currency
- 1.3.2 Limitations
- 1.4 Key Competitors
- SECTION 2 - RESEARCH METHODOLOGY
- 2.1 Research Approach
- 2.2 Data Collection and Validation
- 2.2.1 Secondary Research
- 2.2.2 Primary Research
- 2.3 Market Assessment
- 2.3.1 Market Size Estimation
- 2.3.2 Bottom-up Approach
- 2.3.3 Top-down Approach
- 2.3.4 Growth Forecast
- 2.4 Market Study Assumptions
- 2.5 Data Sources
- SECTION 3 - EXECUTIVE SUMMARY
- 3.1 Global Hybrid Imaging Market, by Technology
- 3.2 Global Hybrid Imaging Market, by Type
- 3.3 Global Hybrid Imaging Market, by SPECT Market
- 3.4 Global Hybrid Imaging Market, by Application
- 3.5 Global Hybrid Imaging Market, by End Use
- 3.6 Global Hybrid Imaging Market, by Geography
- 3.7 Market Position Grid
- SECTION 4 - PREMIUM INSIGHTS
- 4.1 Regulatory Framework
- 4.1.1 Standards
- 4.1.2 Regulatory Landscape
- 4.2 Value Chain Analysis
- 4.3 Supply Chain Analysis
- 4.4 COVID-19 Impact
- 4.5 Russia-Ukraine War Impact
- 4.6 PORTER's Five Force Analysis
- 4.7 PESTLE Analysis
- 4.8 SWOT Analysis
- 4.9 Go to Market Strategy
- 4.10 Opportunity Orbit
- 4.11 Multivariate Modelling
- 4.12 Pricing Analysis
- SECTION 5 - MARKET DYNAMICS
- 5.1 Trends
- 5.1.1 Increasing adoption of hybrid imaging systems in diagnostics and research.
- 5.1.2 Growing integration of advanced technologies like AI and machine learning.
- 5.1.3 Trend 3
- 5.2 Drivers
- 5.2.1 Increasing significance of combination analysis of anatomic and molecular data
- 5.2.2 High prevalence of chronic diseases
- 5.2.3 Driver 3
- 5.2.4 Driver 4
- 5.3 Restraints
- 5.3.1 High cost of hybrid imaging systems.
- 5.3.2 Limited reimbursement policies in some regions.
- 5.3.3 Restraint 3
- 5.4 Opportunities
- 5.4.1 Increasing occurrences of chronic diseases, with cancer
- 5.4.2 Governments of various countries are taking favorable initiatives
- 5.4.3 Opportunity 3
- 5.4.4 Opportunity 4
- 5.5 Challenges
- 5.5.1 Integration challenges with existing healthcare IT systems.
- 5.5.2 Data privacy and security concerns.
- 5.5.3 Challenge 3
- SECTION 6 - GLOBAL HYBRID IMAGING MARKET, BY TECHNOLOGY
- 6.1 Technology Summary
- 6.2 Market Attractive Index
- 6.3 Global Hybrid Imaging Market, by Technology (2019-2032)
- SECTION 7 - GLOBAL HYBRID IMAGING MARKET, BY TYPE
- 7.1 Type Summary
- 7.2 Market Attractive Index
- 7.3 Global Hybrid Imaging Market, by Type (2019-2032)
- SECTION 8 - GLOBAL HYBRID IMAGING MARKET, BY SPECT MARKET
- 8.1 SPECT Market Summary
- 8.2 Market Attractive Index
- 8.3 Global Hybrid Imaging Market, by SPECT Market (2019-2032)
- SECTION 9 - GLOBAL HYBRID IMAGING MARKET, BY APPLICATION
- 9.1 Application Summary
- 9.2 Market Attractive Index
- 9.3 Global Hybrid Imaging Market, by Application (2019-2032)
- SECTION 10 - GLOBAL HYBRID IMAGING MARKET, BY END USE
- 10.1 End Use Summary
- 10.2 Market Attractive Index
- 10.3 Global Hybrid Imaging Market, by End Use (2019-2032)
- SECTION 11 - GLOBAL HYBRID IMAGING MARKET, BY GEOGRAPHY
- 11.1 Regional Summary
- 11.2 Market Attractive Index
- 11.3 Global Hybrid Imaging Market, by Geography (2019-2032)
- SECTION 12 - NORTH AMERICA HYBRID IMAGING MARKET
- 12.1 North America Summary
- 12.2 Market Attractive Index
- 12.3 North America Hybrid Imaging Market, by Technology (2019-2032)
- 12.4 North America Hybrid Imaging Market, by Type (2019-2032)
- 12.5 North America Hybrid Imaging Market, by SPECT Market (2019-2032)
- 12.6 North America Hybrid Imaging Market, by Application (2019-2032)
- 12.7 North America Hybrid Imaging Market, by End Use (2019-2032)
- 12.8 North America Hybrid Imaging Market, by Country (2019-2032)
- 12.8.1 U.S.
- 12.8.2 Canada
- 12.8.3 Mexico
- 12.8.4 Rest of North America
- SECTION 13 - EUROPE HYBRID IMAGING MARKET
- 13.1 Europe Summary
- 13.2 Market Attractive Index
- 13.3 Europe Hybrid Imaging Market, by Technology (2019-2032)
- 13.4 Europe Hybrid Imaging Market, by Type (2019-2032)
- 13.5 Europe Hybrid Imaging Market, by SPECT Market (2019-2032)
- 13.6 Europe Hybrid Imaging Market, by Application (2019-2032)
- 13.7 Europe Hybrid Imaging Market, by End Use (2019-2032)
- 13.8 Europe Hybrid Imaging Market, by Country (2019-2032)
- 13.8.1 Germany
- 13.8.2 U.K.
- 13.8.3 France
- 13.8.4 Italy
- 13.8.5 Spain
- 13.8.6 Russia
- 13.8.7 The Netherlands
- 13.8.8 Belgium
- 13.8.9 Turkey
- 13.8.10 Rest of Europe
- SECTION 14 - ASIA-PACIFIC HYBRID IMAGING MARKET
- 14.1 Asia-Pacific Summary
- 14.2 Market Attractive Index
- 14.3 Asia-Pacific Hybrid Imaging Market, by Technology (2019-2032)
- 14.4 Asia-Pacific Hybrid Imaging Market, by Type (2019-2032)
- 14.5 Asia-Pacific Hybrid Imaging Market, by SPECT Market (2019-2032)
- 14.6 Asia-Pacific Hybrid Imaging Market, by Application (2019-2032)
- 14.7 Asia-Pacific Hybrid Imaging Market, by End Use (2019-2032)
- 14.8 Asia-Pacific Hybrid Imaging Market, by Country (2019-2032)
- 14.8.1 China
- 14.8.2 India
- 14.8.3 Japan
- 14.8.4 South Korea
- 14.8.5 Singapore
- 14.8.6 Malaysia
- 14.8.7 Australia
- 14.8.8 Thailand
- 14.8.9 Philippines
- 14.8.10 Rest of Asia-Pacific
- SECTION 15 - SOUTH AMERICA HYBRID IMAGING MARKET
- 15.1 South America Summary
- 15.2 Market Attractive Index
- 15.3 South America Hybrid Imaging Market, by Technology (2019-2032)
- 15.4 South America Hybrid Imaging Market, by Type (2019-2032)
- 15.5 South America Hybrid Imaging Market, by SPECT Market (2019-2032)
- 15.6 South America Hybrid Imaging Market, by Application (2019-2032)
- 15.7 South America Hybrid Imaging Market, by End Use (2019-2032)
- 15.8 South America Hybrid Imaging Market, by Country (2019-2032)
- 15.8.1 Brazil
- 15.8.2 Argentina
- 15.8.3 Chile
- 15.8.4 Colombia
- 15.8.5 Rest of South America
- SECTION 16 - MIDDLE EAST AND AFRICA HYBRID IMAGING MARKET
- 16.1 Middle East and Africa Summary
- 16.2 Market Attractive Index
- 16.3 Middle East and Africa Hybrid Imaging Market, by Technology (2019-2032)
- 16.4 Middle East and Africa Hybrid Imaging Market, by Type (2019-2032)
- 16.5 Middle East and Africa Hybrid Imaging Market, by SPECT Market (2019-2032)
- 16.6 Middle East and Africa Hybrid Imaging Market, by Application (2019-2032)
- 16.7 Middle East and Africa Hybrid Imaging Market, by End Use (2019-2032)
- 16.8 Middle East and Africa Hybrid Imaging Market, by Country (2019-2032)
- 16.8.1 Kingdom of Saudi Arabia
- 16.8.2 South Africa
- 16.8.3 U.A.E.
- 16.8.4 Egypt
- 16.8.5 Rest of Middle East and Africa
- SECTION 17 - COMPANY SHARE ANALYSIS
- 17.1 Global Hybrid Imaging Market, Company Share Analysis
- 17.2 North America Hybrid Imaging Market, Company Share Analysis
- 17.3 Europe Hybrid Imaging Market, Company Share Analysis
- 17.4 Asia-Pacific Hybrid Imaging Market, Company Share Analysis
- SECTION 18 - COMPANY PROFILES
- 18.1 GE HealthCare
- 18.1.1 Company Snapshot
- 18.1.2 Financial Overview
- 18.1.3 Product Portfolio
- 18.1.4 Recent Developments
- 18.2 Siemens Healthcare
- 18.2.1 Company Snapshot
- 18.2.2 Financial Overview
- 18.2.3 Product Portfolio
- 18.2.4 Recent Developments
- 18.3 Koninklijke Philips N.V.
- 18.3.1 Company Snapshot
- 18.3.2 Financial Overview
- 18.3.3 Product Portfolio
- 18.3.4 Recent Developments
- 18.4 CANON MEDICAL SYSTEMS CORPORATION
- 18.4.1 Company Snapshot
- 18.4.2 Financial Overview
- 18.4.3 Product Portfolio
- 18.4.4 Recent Developments
- 18.5 Shanghai United Imaging Healthcare Co., LTD
- 18.5.1 Company Snapshot
- 18.5.2 Financial Overview
- 18.5.3 Product Portfolio
- 18.5.4 Recent Developments
- 18.6 TTG IMAGING SOLUTIONS (Digirad)
- 18.6.1 Company Snapshot
- 18.6.2 Financial Overview
- 18.6.3 Product Portfolio
- 18.6.4 Recent Developments
- 18.7 Carl Zeiss Meditec AG
- 18.7.1 Company Snapshot
- 18.7.2 Financial Overview
- 18.7.3 Product Portfolio
- 18.7.4 Recent Developments
- 18.8 Topcon Corporation
- 18.8.1 Company Snapshot
- 18.8.2 Financial Overview
- 18.8.3 Product Portfolio
- 18.8.4 Recent Developments
- 18.9 Heidelberg Engineering
- 18.9.1 Company Snapshot
- 18.9.2 Financial Overview
- 18.9.3 Product Portfolio
- 18.9.4 Recent Developments
- 18.10 NIDEK
- 18.10.1 Company Snapshot
- 18.10.2 Financial Overview
- 18.10.3 Product Portfolio
- 18.10.4 Recent Developments
- SECTION 19 - RELATED REPORTS
- SECTION 20 - DISCLAIMER
RESEARCH METHODOLOGY
RESEARCH AND DATA COLLECTION
- Research articles published on Technium
- Science and MDPI
- Research publications by government approved associations and societies
DATA PRE-PROCESSING
The term "data pre-processing" refers to the collection of procedures and methods used to clean, modify, and make ready for analysis the raw data gathered during research and data collection. The completion of this phase is necessary to guarantee that the data are reliable, consistent, and appropriate for statistical analysis and other data-driven tasks. The data pre-processing ensures that the information gathered from research and data collection is comparable and expressed in standard units, by the integration of missing data pointers and algorithmic approaches.
MODELING AND FORECASTING
QUALITY ASSURANCE AND OUTPUT
Quality assurance and output involves the process of validation, adjustments, further publications of key market indicators. Extensive plausibility and consistency tests are performed on derived time series to ensure the high degree of quality of our market analysis. This quality assurance procedure also includes rigorous inspection, validation, and editing by an experienced management team to assure the dependability of the published data.